Trial intelligence / Profile preview

PRIMA-KOST: Transit Time and Gut Microbiome

NCT06022302Completed

Sponsor
University of Copenhagen
Start
Oct 2023
Primary completion
Nov 2024
Modality
Polymer-based Nanoparticles
Countries
1
01

Overview

Randomised, open-label trial of polyethylene glycol in constipation (2 arms), sponsored by University of Copenhagen. Primary endpoint: Fecal butyrate over urine p-cresol sulfate ratio at 7 weeks. Started Oct 2023; status: completed.

02

Drugs

polyethylene glycol
03

Conditions

constipation

Beyond the preview

Go deeper on NCT06022302.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06022302.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call